Drag a card by its title · ⚙ to size, swap or remove

The company

PharmaCyte Biotech, Inc.

PMCB · Nasdaq

Health CareBiotechnologyNot moving yet

PMCB stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 46.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 52
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $257K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 26 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6

Sale orders, 12 months0

Buyers · sellers2 · 0

Who	Did	Shares	Traded
Jonathan SchechterDirector	bought	20,000at $0.8436	7 Jan 2026filed 7 Jan 2026
Joshua SilvermanCEO and President	bought	40,000at $0.8329	7 Jan 2026filed 7 Jan 2026
Jonathan SchechterDirector	bought	20,000at $0.7904	6 Jan 2026filed 7 Jan 2026
Joshua SilvermanCEO and President	bought	30,000at $0.7889	6 Jan 2026filed 7 Jan 2026
Jonathan SchechterDirector	bought	20,000at $0.7776	5 Jan 2026filed 7 Jan 2026
Joshua SilvermanCEO and President	bought	30,000at $0.7831	5 Jan 2026filed 7 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders26-3 on the quarter

New · exited3 · 6

Reported value$575K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
CITADEL ADVISORS LLCreduced · filed 14 Aug 2026	283,381$218K	-76,166−21.2%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	124,247$96K	-71,413−36.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	56,778$44K	+5,311+10.3%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 2026	44,853$35K	+44,853
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026	37,987$29K	-18,513−32.8%
XTX Topco Ltdreduced · filed 14 Aug 2026	34,180$26K	-18,182−34.7%
NORTHERN TRUST CORPreduced · filed 13 Aug 2026	32,624$25K	-2,977−8.4%
JANE STREET GROUP, LLCadded · filed 14 Aug 2026	30,064$23K	+18,534+160.7%
Schonfeld Strategic Advisors LLCreduced · filed 14 Aug 2026	26,926$21K	-83−0.3%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	23,452$18K	00.0%